Recent Quotes (30 days)

You have no recent quotes
chg | %

Cipher Pharmaceuticals Inc  

(Public, TSE:CPH)   Watch this stock  
Find more results for TSE:DND
+0.58 (4.92%)
Mar 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 11.80 - 12.50
52 week 7.38 - 19.52
Open 11.80
Vol / Avg. 98,361.00/93,191.00
Mkt cap 320.02M
P/E 15.60
Div/yield     -
EPS 0.79
Shares 25.89M
Beta -0.76
Inst. own     -
Mar 3, 2015
Cipher Pharmaceuticals Inc at Cowen Health Care Conference
Feb 25, 2015
Q4 2014 Cipher Pharmaceuticals Inc Earnings Release
Feb 25, 2015
Q4 2014 Cipher Pharmaceuticals Inc Earnings Call - Webcast

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 42.83% 63.96%
Operating margin 53.70% 61.27%
EBITD margin - 67.80%
Return on average assets 19.86% 31.23%
Return on average equity 23.98% 40.69%
Employees 13 -
CDP Score - -


5650 Tomken Road, Unit 16
+1-905-6025840 (Phone)
+1-905-6020628 (Fax)

Website links


Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops improved formulations of known molecules using drug delivery technologies. The Company is engaged in clinical and regulatory affairs, product licensing, supply chain management, and marketing and sales. The Company has three commercial products and a fourth in development. Its products include Absorica/Epuris, Lipofen and ConZi/Durela. The Company is focused on growth through new products, additional out-licensing agreements.

Officers and directors

Gerald P. McDole Independent Chairman of the Board
Age: 74
Shawn Patrick O'Brien President, Chief Executive Officer
Norman C. Evans Chief Financial Officer, Secretary
Age: 60
Joan Chypyha Vice President - Marketing and Sales
Linda Melanie Angaritis Vice President - Global Regulatory Compliance and Quality
Lynne Bulger Vice President - Medical and Clinical Affairs
Peter Weiler Vice President - Business Development
Stefan Aigner M.D. Independent Director
William D. Claypool M.D. Independent Director
Age: 61
John D. Mull M.D. Independent Director